| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10745410 | Parkinsonism & Related Disorders | 2014 | 6 Pages |
Abstract
Our results indicated that the methylation level of SNCA CpG-2, especially that of the 2nd, 4th and 9th CpG sites in leukocytes might have great potential to be a useful and informative biomarker in PD diagnosis and treatment.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Yu-yan Tan, Li Wu, Zong-bo Zhao, Ying Wang, Qin Xiao, Jun Liu, Gang Wang, Jian-fang Ma, Sheng-di Chen,